Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Guided Bone Regeneration: biological principle and therapeutic applications
Countries citing papers authored by Nicolaos Donos
Since
Specialization
Citations
This map shows the geographic impact of Nicolaos Donos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolaos Donos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolaos Donos more than expected).
This network shows the impact of papers produced by Nicolaos Donos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolaos Donos. The network helps show where Nicolaos Donos may publish in the future.
Co-authorship network of co-authors of Nicolaos Donos
This figure shows the co-authorship network connecting the top 25 collaborators of Nicolaos Donos.
A scholar is included among the top collaborators of Nicolaos Donos based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Nicolaos Donos. Nicolaos Donos is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Sculean, Anton, Péter Windisch, Tibor Keglevich, et al.. (2003). Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine-derived xenograft.. PubMed. 23(1). 47–55.67 indexed citations
7.
Sculean, Anton, et al.. (2001). Effect of an enamel matrix protein (Emdogain (R)) on ex vivo dental plaque vitality. UCL Discovery (University College London).1 indexed citations
8.
Sculean, Anton, et al.. (2000). Enamel matrix proteins and GTR in the treatment of intrabony defects. Three year results of a split-mouth study. UCL Discovery (University College London).1 indexed citations
9.
Sculean, Anton, et al.. (2000). Healing of recession-type defects following treatment with enamel matrix proteins or guided tissue regeneration. A pilot study in monkeys. UCL Discovery (University College London).10 indexed citations
10.
Sculean, Anton, Giovanni Carlo Chiantella, Péter Windisch, & Nicolaos Donos. (2000). Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain).. PubMed. 20(4). 374–81.125 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.